| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 16.723 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | -16.723 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | -16.723 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Iris 94 Comprodexim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.168 | 19.962 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 26.093 | 25.827 | 4.306 | 4.227 | 4.155 | 4.076 | 3.986 | 3.998 | 3.986 | 3.964 |
| Inventories | 8.090 | 8.007 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.572 | 4.525 | 4.306 | 4.227 | 4.155 | 4.076 | 3.985 | 3.998 | 3.986 | 3.963 |
| Cash | 13.431 | 13.294 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Shareholders Funds | 4.227 | 4.184 | -12.610 | -12.379 | -12.139 | -11.909 | -11.645 | -11.681 | -11.645 | -11.580 |
| Social Capital | 1.428 | 1.413 | 1.389 | 1.364 | 1.337 | 1.312 | 1.283 | 1.287 | 1.283 | 1.276 |
| Debts | 44.645 | 44.190 | 16.916 | 16.606 | 9.762 | 9.577 | 9.365 | 9.394 | 9.365 | 9.313 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4641 - 4641" | |||||||||
| CAEN Financial Year |
4641
|
|||||||||
Comments - Iris 94 Comprodexim S.r.l.